| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.02 | 0.8 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.8 |